Table 7.
Summary of other studies on Fok I in ovarian cancer
| Study | Study population | Patient/control participant | Odds ratio FFvsFf/ff | C.I (95%) | p value |
|---|---|---|---|---|---|
| Lurie et al. 2007 [10] |
U.S |
|
|
|
|
| Caucasian |
71/144 |
FF 1 |
Reference |
0.04 |
|
| Japanese |
93/172 |
Ff 2.5 |
1.3-4.8 |
|
|
|
ff 2.1 |
0.8-5.2 |
||||
|
FF 1 |
Reference |
0.87 |
|||
|
Ff 1.2 |
0.7-2.0 |
|
|||
|
ff 0.9 |
0.4-2.2 |
||||
| Clendenen et al. 2008 [11] |
U.S + Sweden |
168/321 |
FF 1 |
Reference |
0.55 |
|
Ff 1.10 |
0.67-1.81 |
|
|||
|
ff 1.23 |
0.61-2.51 |
||||
| Tworoger et al. 2009 [12] |
U.S |
1473/2006 |
1.16 |
1.00-1.35 |
0.03 |
| Lurie et al. 2010 [13] | U.S | 1820/3479 | 1.14 | 1.01-1.28 | 0.03 |